|
|
|
|
|
DUBAI, UAE, Nov 28, 2016 - (ACN Newswire) - AugmentCare, an integrated digital healthcare platform focused on emerging markets, has announced the appointment of Privity FZ LLE, an independent venture-focused advisory firm, to assist in its first round of fundraising and the rolling-out of its public beta in Pakistan early next year (1Q2017).
AugmentCare ('AC') has built a platform which will connect patients, doctors, care facilities, payers and corporates, while providing the most comprehensive information for preventative, diagnostic and care facilitation. The AC solution set focuses on the patient journey across the continuum of care and addresses the challenges faced by all key stakeholders - patients, providers, doctors, caregivers, payers, corporates, pharmacists and diagnostics - with a particular understanding of Pakistan's healthcare system.
"What sets AugmentCare apart is our integrated approach and attention to a broad value chain, from discovery to care coordination, and remote monitoring to medicine fulfilment," said Ammar Afif, an AugmentCare co-founder. "This enables AC to empower all stakeholders in the care delivery process. It also differentiates AC from competitors that are solely focused on individual silos of this chain."
"At AugmentCare, we believe in the kind of innovation which transforms our lives into a virtual hyper connected reality, only making life so much sweeter. Being research and data driven, design-led and human-focused has helped us uncover the need for a comprehensive platform for the entire healthcare ecosystem. Doctors have shown an optimistic and keen interest in our private beta," said Ahmed Shuja, second co-founder of AugmentCare. "We have our first of set of doctors using the platform who will help us define the future of patient-first healthcare."
Hyder Mumtaz, the third AugmentCare co-founder, added, "Research has shown us that almost 50% of patients are self-medicating because of the low doctor patient ratios (1:1200+) and concentration in urban cities. These numbers are symptoms of the inefficiencies in the healthcare delivery process in Pakistan. We're positioned at the center of a fragmented healthcare system and want to enable all stakeholders to evolve towards preventive health behaviour and less out of pocket spend."
Sleem Hasan, Privity Founder & CEO, adds "I was most impressed by the backgrounds and professionalism of the AugmentCare co-founders, and feel fortunate that Privity was selected in partnering at this early stage. Privity grasps the potential of this platform in frontier and emerging markets. The AC machine learning focus will leverage data to build clinical support tools which demonstrate that prevention is truly cheaper than cure. We look forward to being part of this growth story in the years ahead."
About Privity
Privity FZ LLE was founded in 2004, an independent venture-focused advisory firm that seeks entrepreneurs with interesting and unique ideas and helps them develop and grow. Privity is agnostic to geography and industry vertical. It focuses on the quality of the entrepreneur and the compelling value proposition of the idea.
Privity draws upon its unique 4i methodology - ideas, intelligence, innovation, invention - to deliver insightful advisory and consulting services. This methodology is a result of Privity's diverse experience accumulated over the years as well as its highly specialized deep domain expertise which yields unique results for its clients. For more information, please visit www.privitylle.com.
About AugmentCare
AugmentCare operates an integrated digital health platform which connects patients, providers, care facilities, payers and corporates, while providing the most comprehensive information for preventative, diagnostic and care facilitation. A patient-first approach enables AugmentCare to address key issues faced by care seekers in emerging economies.
AugmentCare Inc. is a Dubai-based Delaware incorporated company focusing on emerging economies, starting with Pakistan. Partners include Basehealth (USA) and Sehat (Pakistan). For more information please visit www.augmentcare.com. You can also follow us on Facebook at facebook.com/augmentcare/, Instagram at instagram.com/augmentcare/ or Twitter at @AugmentCare.
Media Contact:
Hyder Mumtaz
AugmentCare
+92 333 420 6455
+97 155 295 5179
hyder@augmentcare.com
Topic: Press release summary
Source: Privity / AugmentCare
Sectors: Daily Finance, Daily News, Healthcare & Pharm, PE, VC & Alternatives, Digitalization, Regional
http://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
|
|
|
|
|
|
Latest Press Releases
Magnolia Welcomes Tech Pioneer Luc Haldimann as New Board Chairman to Expand Global Growth and AI Strategy
Nov 28, 2025 00:00 HKT/SGT
|
|
|
NEC Launches Sales Support Solution Utilizing Agentic AI
Thursday, November 27, 2025 9:31:00 PM
|
|
|
Fujitsu and Yamaguchi University develop low-power edge computing technology for near real-time image processing on small satellites
Thursday, November 27, 2025 9:00:00 PM
|
|
|
Tat Hong Equipment Service Co., Ltd. Announces 2025/26 Interim Results
Nov 27, 2025 18:43 HKT/SGT
|
|
|
PLN Collaborates with Norwegian and Japanese Stakeholders to Advance High-Integrity Cross-Border Carbon Markets at COP30 
Nov 27, 2025 18:30 HKT/SGT
|
|
|
Geespace Accelerates Global Expansion as GEESATCOM Enters New Markets
Nov 27, 2025 15:30 HKT/SGT
|
|
|
KEF, the premium speaker brand of Gold Peak, partners with Huawei to unlock new wireless high-fidelity experience with HUAWEI HiPlay
Nov 27, 2025 13:29 HKT/SGT
|
|
|
World's first ever spiral escalator renewal project conducted at a commercial facility in Mexico
Thursday, November 27, 2025 10:00:00 AM
|
|
|
CBL International Limited Wins Prestigious 'CGMA Excellent Sustainability Award' at the CGMA Annual Awards 2025
Nov 26, 2025 18:54 HKT/SGT
|
|
|
Eisai Completes Rolling Submission to US FDA for LEQEMBI(R) IQLIK(TM) (lecanemabirmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease Under Fast Track Status
Wednesday, November 26, 2025 6:42:00 PM
|
|
|
|
|
More Press release >> |
|
 |
|
 |
|
